# Dongnao Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dongnao-medical

- Headquarters: Tianjin, China
- Latest round: Seed (Apr 17, 2026)
- Investors on record: 1

## About

Based in Tianjin, China and founded in 2023, Dongnao Medical Technology (Tianjin) Co., Ltd., trading as Dongnao Medical, is a brain-computer interface technology developer. In April 2026, Dongnao Medical raised a Seed funding from Zhongdian Shurong Investment Management.
The company primarily engages in the research and development and clinical validation of brain-computer interface monitoring technologies. It is committed to solving the clinical need for "non-invasive, real-time, and accurate" monitoring of parameters such as cerebral oxygenation, intracranial pressure, blood pressure, and hemodynamics.
The company generates revenue by doing R&D, and providing brain-computer interface monitoring technologies and other related services.
The Seed funding round raised in April 2026 will primarily be used to accelerate the large-scale promotion of certified products, clinical validation of world-first products under development, and in-depth development of brain-computer interface fusion monitoring technology.

## Funding rounds

- Seed, Apr 17, 2026 — Zhongdian Shurong Investment Management

## Investors

- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Seed